Study reveals CADM patients face twice the misdiagnosis rate of DM patients, with diagnostic delays associated with increased hospitalization and ILD risks.
New research has found intranasally administered esketamine's effects are short-lived. tDCS shows promise for depression, ondansetron has limited OCD impact, and Cobenfy enhances cognition in schizophrenia.
COVID-19 infection significantly increases autoimmune blistering disease risk, while vaccination appears protective, researchers report in a study analyzing 112 million patient records